Bcl-2 is a critical mediator of intestinal transformation
Maartje van der Heijden(Oncode Institute), Louis Vermeulen(Genesys (United States))
Cited by 72
Related Papers
From tumour heterogeneity to advances in precision treatment of colorectal cancer
|Nature Reviews Clinical Oncology|2016|692
Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer
|Nature Cell Biology|2018|172
Cyclooxygenase-2 Inhibition Inhibits c-Met Kinase Activity and Wnt Activity in Colon Cancer
|Cancer Research|2008|129